126 related articles for article (PubMed ID: 23519203)
1. Synthesis and antiviral activity of N-phenylbenzamide derivatives, a novel class of enterovirus 71 inhibitors.
Ji XY; Wang HQ; Hao LH; He WY; Gao RM; Li YP; Li YH; Jiang JD; Li ZR
Molecules; 2013 Mar; 18(3):3630-40. PubMed ID: 23519203
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Smee DF; Evans WJ; Nicolaou KC; Tarbet EB; Day CW
Antiviral Res; 2016 Jul; 131():61-5. PubMed ID: 27063860
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses.
Xue F; Luo X; Ye C; Ye W; Wang Y
Bioorg Med Chem; 2011 Apr; 19(8):2641-9. PubMed ID: 21441033
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antiviral activity studies of schizonepetin derivatives.
Bao B; Meng Z; Li N; Meng Z; Zhang L; Cao Y; Yao W; Shan M; Ding A
Int J Mol Sci; 2013 Aug; 14(8):17193-203. PubMed ID: 23965980
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates.
Wang Y; Wang H; Jiang X; Jiang Z; Guo T; Ji X; Li Y; Li Y; Li Z
Molecules; 2019 Mar; 24(5):. PubMed ID: 30862068
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antiviral activity of novel pyridazines.
Wang Z; Wang M; Yao X; Li Y; Tan J; Wang L; Qiao W; Geng Y; Liu Y; Wang Q
Eur J Med Chem; 2012 Aug; 54():33-41. PubMed ID: 22608761
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agents.
Sethy B; Hsieh CF; Yeh C; Horng JT; Hsieh PW
Future Med Chem; 2018 Jun; 10(11):1333-1347. PubMed ID: 29745776
[TBL] [Abstract][Full Text] [Related]
10. Novel substituted heteroaromatic piperazine and piperidine derivatives as inhibitors of human enterovirus 71 and coxsackievirus a16.
Zhang X; Wang H; Li Y; Cao R; Zhong W; Zheng Z; Wang G; Xiao J; Li S
Molecules; 2013 Apr; 18(5):5059-71. PubMed ID: 23629759
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activities of 3-aralkylthiomethylimidazo[1,2-b]pyridazine derivatives.
Galtier C; Mavel S; Snoeck R; Andreï G; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E; Gueiffier A
Antivir Chem Chemother; 2003 Jul; 14(4):177-82. PubMed ID: 14582846
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of 2'-acetylene-7-deaza-adenosine phosphoamidate derivatives as anti-EV71 and anti-EV-D68 agents.
Yan L; Cao R; Zhang H; Li Y; Li W; Li X; Fan S; Li S; Zhong W
Eur J Med Chem; 2021 Dec; 226():113852. PubMed ID: 34560428
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity.
Barnard DL; Hubbard VD; Smee DF; Sidwell RW; Watson KG; Tucker SP; Reece PA
Antimicrob Agents Chemother; 2004 May; 48(5):1766-72. PubMed ID: 15105133
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors.
Shia KS; Li WT; Chang CM; Hsu MC; Chern JH; Leong MK; Tseng SN; Lee CC; Lee YC; Chen SJ; Peng KC; Tseng HY; Chang YL; Tai CL; Shih SR
J Med Chem; 2002 Apr; 45(8):1644-55. PubMed ID: 11931618
[TBL] [Abstract][Full Text] [Related]
18. Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors.
Han X; Sun N; Wu H; Guo D; Tien P; Dong C; Wu S; Zhou HB
J Med Chem; 2016 Mar; 59(5):2139-50. PubMed ID: 26885567
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
20. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
